newsfilter
← Latest News
GlobeNewswire·

Equillium to Participate in Oppenheimer's 2026 Innovation on the Island Event

EQ

LA JOLLA, Calif., April 20, 2026 (GLOBE NEWSWIRE) -- Equillium, Inc. (NASDAQ:EQ), a biotechnology innovator developing novel therapies to treat severe autoimmune and inflammatory disorders, today announced that